This systematic review provides a high-quality, comprehensive summary of recommendations on hypertension (HT) and type 2 diabetes mellitus (T2DM), accentuating patient blood pressure, HbA1c levels, patterns of drug treatment, management, and screening of these diseases. The overall objective of the revie...
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glucemia,
Terapia Combinada,
Diabetes Mellitus Tipo 1,
Diabetes Mellitus Tipo 2,
Dieta para Diabéticos,
Monitoreo de Drogas,
Endocrinología,
Hiperglucemia,
Hipoglucemia,
Insulina/uso terapéutico,
Sistemas de Infusión de Insulina,
Monitoreo Ambulatorio,
Educación del Paciente como Asunto,
Medicina de Precisión,
Diabetes Mellitus Tipo 1/tratamiento farmacológico,
Diabetes Mellitus Tipo 2/tratamiento farmacológico,
Diabetes Mellitus Tipo 1/terapia,
Diabetes Mellitus Tipo 2/terapia,
Hipoglucemiantes/uso terapéutico,
Hipoglucemiantes/efectos adversos,
Insulina/efectos adversos